3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Ovarian Neoplasms
1
Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Ovarian Epithelial
1
Biliary Tract Neoplasms
1
Interventions
Gemcitabine
35
Cisplatin
21
Capecitabine
17
Oxaliplatin
16
Leucovorin
11
Fluorouracil
11
pembrolizumab
8
S 1 (combination)
8
Nivolumab
6
tremelimumab
5
durvalumab
5
Bevacizumab
5
lenvatinib
4
Irinotecan
4
trametinib
3
titanium silicide
3
atezolizumab
3
Radiofrequency Ablation
3
zanidatamab
2
vandetanib
2
irinotecan sucrosofate
2
derazantinib
2
camrelizumab
2
binimetinib
2
apatinib
2
Trastuzumab
2
Tegafur
2
Radiotherapy
2
Panitumumab
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Biliary Tract Neoplasms
×
NUC-1031
×
Clear all
NCT02351765
2023-05-17
ABC-08
The Christie NHS Foundation Trust
Phase 1
Completed
21 enrolled